T3050 |
ML-7 hydrochloride
|
110448-33-4
|
99.61%
|
|
ML-7 hydrochloride (ML-7 HCl) is a cell-permeable, reversible, effective, ATP-competitive, and specific inhibitor of myosin light chain kinase (Ki: 300 nM); also...
|
T1418 |
Bucladesine sodium
|
16980-89-5
|
99.58%
|
|
Bucladesine sodium (DC2797) is a cAMP analog with cell-permeable properties. Bucladesine sodium is also a cAMP-dependent protein kinase (PKA) activator and a pho...
|
T6139L |
A-674563 2HCl(552325-73-2(fb-2hcl))
|
T6139L
|
99.57%
|
|
A-674563 2HCl is an Akt1 inhibitor with Ki of 11 nM, modest potent to PKA and >30-fold selective for Akt1 over PKC.
|
T19836 |
2-Aminopurine
|
452-06-2
|
99.51%
|
|
2-Aminopurine is a double-stranded RNA-dependent protein kinase, protein kinase R (PKR) inhibitor.
|
TP1957L |
PKI (5-24) Acetate(99534-03-9 free base)
|
TP1957L
|
99.47%
|
|
PKI (5-24) Acetate is a high affinity PKA inhibitor (Ki = 2.3 nM).
|
T0610 |
Piceatannol
|
10083-24-6
|
99.39%
|
|
Piceatannol (Astringenin) is an anti-inflammatory, immunomodulatory and antiproliferative agent. It inhibits p56lck and syk protein tyrosine kinases and inhibits...
|
T1837 |
BX-912
|
702674-56-4
|
99.34%
|
|
BX-912 is a specific inhibitor of 3-Phosphoinositide-dependent Kinase-1 (PDK1, IC50: 12 nM). The selectivity of BX-912 is more 10 fold than C-Kit, EGFR, PKA, PKC...
|
T77504 |
JAK1/2/3 Inhibitor 1
|
16234-14-3
|
99.32%
|
|
JAK1/2/3 Inhibitor 1 is a potent protein kinase inhibitor.JAK1/2/3 Inhibitor 1 has antitumor activity that inhibits the growth of a variety of cancer cell lines....
|
T21674L |
PKA inhibitor fragment (6-22) amide Acetate
|
T21674L
|
99.30%
|
|
PKA inhibitor fragment (6-22) amide Acetate is a synthetic peptide which selectively inhibits PKA activity by binding to its substrate site (IC50 < 2 nM).
|
TP1787L |
PKG Substrate acetate(81187-14-6 free base)
|
TP1787L
|
99.30%
|
|
PKG Substrate acetate is a selective substrate for cGMP-dependent protein kinase (PKG).PKG Substrate is a selective substrate for protein kinase G (PKG) with a s...
|
T6680 |
Staurosporine
|
62996-74-1
|
99.24%
|
|
Staurosporine (AM-2282) is a protein kinase inhibitor with ATP-competitive and non-selective inhibitory activity (IC50=6/15/2/3/3000 nM) against PKC, PKA, c-Fgr,...
|
T6139 |
A-674563
|
552325-73-2
|
99.21%
|
|
A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest potent to PKA and >30-fold selective for Akt1 over PKC.
|
T6303 |
CCT128930
|
885499-61-6
|
99.18%
|
|
CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 with IC50 of 6 nM, 28-fold greater selectivity for Akt2 than the closely related PKA kinas...
|
T6315 |
MLN8054
|
869363-13-3
|
99.05%
|
|
MLN8054 is a potent and selective Aurora A kinase inhibitor with an IC50 of 4 nM.
|
T27525 |
HA-1004
|
91742-10-8
|
99.03%
|
|
HA-1004 is a inhibitor of PKG, PKA, PKC and MLC.
|
T2482 |
AT13148
|
1056901-62-2
|
99%
|
|
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
|
T4276L |
Hydroxyfasudil
|
105628-72-6
|
98.79%
|
|
Hydroxyfasudil (Hydroxy-Fasudil) is a ROCK inhibitor(IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively).
|
T13807 |
OSIP-486823
|
200803-37-8
|
98.59%
|
|
OSIP-486823(CP248) is a novel and potent microtubule disruptor with affinity for both protein kinase G (PKG) and microtubules.
|
T6303L |
CCT128930 hydrochloride
|
2453324-32-6
|
98.55%
|
|
CCT128930 hydrochloride (CCT128930 hydrochloride) is a potent and selective inhibitor of AKT with IC50 of 6 nM. CCT128930 hydrochloride induces cell cycle arrest...
|
T3513 |
GSK180736A
|
817194-38-0
|
98.16%
|
|
GSK180736A is an effective and selective GRK2 inhibitor (IC50: 0.77 μM) and >100-fold selectivity over other GRKs. It is a weak inhibitor of PKA (IC50: 30 μM), b...
|